The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens-Reference-Cited by-同舟云学术

The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens

Published:2000-09-15 Issue:6 Volume:165 Page:3301-3308
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Haicheur Nacilla,Bismuth Emmanuelle,Bosset Sophie,Adotevi Olivier,Warnier Guy,Lacabanne Valérie,Regnault Armelle,Desaymard Catherine,Amigorena Sebastian,Ricciardi-Castagnoli Paola,Goud Bruno,Fridman Wolf H.,Johannes Ludger,Tartour Eric

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference63 articles.

1. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

2. Efficiency of peptides and lipopeptides forin vivo priming of virus-specific cytotoxic T cells

3. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

4. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers;Expert Review of Vaccines;2024-07-08

2. A synthetic delivery vector for mucosal vaccination;2023-05-16

3. Engineered Synthetic STxB for Enhanced Cytosolic Delivery;Cells;2023-04-30

4. Les cancers des voies aérodigestives supérieures induits par une infection par Papillomavirus humain : spécificités épidémiologiques, diagnostiques, pronostiques et thérapeutiques;Bulletin de l'Académie Nationale de Médecine;2023-03

5. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context;BioDrugs;2023-02-02